Pharmaceutical Manufacturing Handbook: Production and

388 CONTROLLED-RELEASE DOSAGE FORMS
38. Hui , H. W. , Lee , V. H. L. , and Robinson , J. R. ( 1987 ), Design and fabrication of oral
controlled release drug delivery systems , in Controlled Drug Delivery: Fundamentals and
Applications , Marcel Dekker , New York , pp. 373 – 421 .
39. Anal , A. K. , and Singh , H. ( 2007 ), Recent advances in microencapsulation of probioitcs
for industrial applications and targeted delivery , Trends Food Sci. Technol. , 18 , 240 – 251 .
40. Mathir , Z. M. , Dangor , C. M. , Govender , T. , and Chetty , D. J. ( 1997 ), In vitro characterization
of a controlled - release chlorpheniramine maleate delivery system prepared by
the air - suspension technique , J. Microencapsul. , 14 , 743 – 751 .
41. Deasy , P. B. ( 1991 ), Microencapsulation of drugs by pan and air suspension techniques ,
Crit. Rev. Ther. Drug Carrier Syst. , 8 , 39 – 89 .
42. O ’ Connor , R. E. , and Schwartz , J. B. ( 1989 ), Extrusion and spheronization technology ,
in Pharmaceutical Pelletization Technology , Marcel Dekker , New York , pp. 187 – 215 .
43. Gopferich , A. , Alonso , M. J. , and Langer , R. ( 1994 ), Development and characterization
of microencapsulated microspheres , Pharm. Res. , 11 , 1568 – 1574 .
44. Anal , A. K. , Stevens , W. F. , and L ó pez , C. R. ( 2006 ), Ionotropic cross - linked chitosan
microspheres for controlled release of ampicillin , Int. J. Pharm. , 312 , 166 – 173 .
45. Weidenauer , U. , Bodmeier , D. , and Kissel , T. ( 2003 ), Microencapsulation of hydrophilic
drug substances using biodegradable polyesters. Part I: Evaluation of different techniques
for the encapsulation of pamidronate di - sodium salt , J. Microencapsul. , 20 ,
509 – 524 .
46. Cui , J. H. , Goh , J. S. , Park , S. Y. , Kim , P. H. , and Le , B. J. ( 2001 ), Preparation and physical
characterization of alginate microparticles using air atomization method , Drug Dev. Ind.
Pharm. , 27 , 309 – 319 .
47. Purvis , T. , Vaughan , J. M. , Rogers , T. L. , Chen X. , Overhoff , K. A. , Sinswat , P. , Hu , J. ,
McConville , J. T. , Johnston , K. P. , and Williams , R. O. ( 2006 ), Cryogenic liquids, nanoparticles,
and microencapsulation , Int. J. Pharm. , 4 , 43 – 50 .
48. Charman , W. N. , Chan , H. K. , Finnin , B. C. , and Charman , S. A. ( 1999 ), Drug delivery:
A key factor in realizing the full therapeutic potential of drugs , Drug Dev. Res. , 46 ,
316 – 327 .
49. Kayser , O. , Lemke , A. , and Hern á ndez - Trejo , N. ( 2005 ), The impact of nanobiotechnolgy
on the development of new drug delivery systems , Curr. Pharm. Biotechnol. , 6 , 3 – 5 .
50. Roco , M. C. ( 2003 ), Nanotechnology: Convergence with modern biology and medicine ,
Curr. Opin. Biotechnol. , 14 , 337 – 346 .
51. Merck & Co. ( 2004 ), Drug Information: Emend, capsules, available: www.merck.com.
52. Liversidge , G. G. , Cundy , K. C. , Bishop , J. F. , and Czekai , D. A. ( 1992 ), Surface modifi ed
drug nanoparticles, Un. St. Patent 5,145,684 , Sterling Drug, New York.
53. Merisko - Liversidge , E. , Liversidge , G. G. , and Cooper , E. R. ( 2003 ), Nanosizing: A formulation
approach for poorly water - soluble compounds , Eur. J. Pharm. Sci. , 18 ,
113 – 120 .
54. Merisko - Liversidge , E. , Sparpotdar , P. , and Bruno , J. ( 1996 ), Formulation and antitumor
activity evaluation of nanocrystalline suspension of poorly soluble anticancer drugs ,
Pharm. Res. , 13 , 272 – 278 .
55. Buchmann , S. , Fischli , W. , Thiel , F. P. , and Alex , R. ( 1996 ), Aqueous microsuspension, an
alternative intravenous formulation for animal studies, paper presented at the 42nd
Annual Congress of the International Association for Pharmaceutical Technology,
Mainz, p. 124 .
56. M ü ller , R. H. , and Heinemann , S. ( 1989 ), Surface modeling of microparticles as parenteral
systems with high tissue affi nity , in Bioadhesion - Possibilities and Future Trends ,
Wissenschaftliche Verlagsgesellschaft , Stuttgart , pp. 202 – 214 .